Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind Phase III trial of VGR-R01 in Bietti crystalline dystrophy
CTR20244386Phase 3Active
- Sponsor
- T-MAXESTATE
- Start
- Dec 2024
- Modality
- Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of VGR-R01 in Bietti crystalline dystrophy (BCD), sponsored by T-MAXESTATE. Started Dec 2024; status: active.
02
Drugs
VGR-R01
03
Conditions
Bietti crystalline dystrophy (BCD)
Beyond the preview
Go deeper on CTR20244386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244386.